U.S., Sept. 27 -- ClinicalTrials.gov registry received information related to the study (NCT07194824) titled 'A Penicillin Allergy Delabeling Inhospital Model Hospitalized Patients' on Sept. 19.
Brief Summary: Design, implementation and analysis of an allergy assessment and management model beta-lactams in hospitalized patients
Study Start Date: April 04, 2024
Study Type: INTERVENTIONAL
Condition: 
Evaluation and Management Model for Beta-lactam Allergy in Hospitalized Patients
Intervention: 
OTHER: Pragmatic allergy management according to risk stratification
Intervention based on allergy risk stratification. Tipus A) Patients in this group can undergo direct delabeling without the need for exposure, with this being documented in the...